IP Library › Granted Patent US 9,957,274
Granted Patent B2
US 9,957,274 · App. 15/588,398 · Granted May 1, 2018

Indane inhibitors of EED and methods of their use

Inventors: Michael R. Michaelides (Libertyville, IL); Michael L. Curtin (Pleasant Prairie, WI); Huan-Qiu Li (Wilmette, IL); Marina A Pliushchev (Vernon Hills, IL); Ying Wang (Libertyville, IL); Hongyu H. Zhao (Libertyville, IL); Richard F. Clark (Gurnee, IL); Alan S. Florjancic (Kenosha, WI); Zhiqin Ji (Libertyville, IL); Mariazel Torrent (Lake Bluff, IL); Ramzi F. Sweis (Lake Bluff, IL); Anil Vasudevan (Union Grove, WI); Justin D. Dietrich (Lidenhurst, IL)
Assignee: AbbVie Inc.
C07D487/04A61K31/40C07D207/14C07D401/04C07D401/12C07D401/14C07D403/04C07D403/10C07D403/12C07D403/14C07D405/04C07D413/10C07D417/14C07D471/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,957,274
App. No.
15/588,398
Granted
May 1, 2018
Kind
B2
Abstract

Compounds having a structure of Formula (I): or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, wherein A 1 , A 2 , A 3 , A 4 , A 5 , n, and m are as defined herein and are provided. Pharmaceutical compositions comprising such compounds and methods for treating various EED-related conditions or diseases, including cancer, by administration of such compounds are also provided.

Claims (194)

1. A compound of Formula (I), or a pharmaceutically acceptable salt thereof,

wherein

A 1 and A 2 are each independently C 1 -C 2 alkyl;

A 3 is selected from the group consisting of aryl, heterocyclyl, and heteroaryl, wherein the A 3 aryl, heterocyclyl, and heteroaryl are optionally substituted with one or more substituents independently selected from the group consisting of R 1 , OR 1 , SR 1 , S(O)R 1 , SO 2 R 1 , C(O)R 1 , CO(O)R 1 , OC(O)R 1 , OC(O)OR 1 , NH 2 , NHR 1 , N(R 1 ) 2 , NHC(O)R 1 , NR 1 C(O)R 1 , NHS(O) 2 R 1 , NR 1 S(O) 2 R 1 , NHC(O)OR 1 , NR 1 C(O)OR 1 , NHC(O)NH 2 , NHC(O)NHR 1 , NHC(O)N(R 1 ) 2 , NR 1 C(O)NHR 1 , NR 1 C(O)N(R 1 ) 2 , C(O)NH 2 , C(O)NHR 1 , C(O)N(R 1 ) 2 , C(O)NHOH, C(O)NHOR 1 , C(O)NHSO 2 R 1 , C(O)NR 1 SO 2 R 1 , SO 2 NH 2 , SO 2 NHR 1 , SO 2 N(R 1 ) 2 , C(O)H, C(O)OH, C(N)NH 2 , C(N)NHR 1 , C(N)N(R 1 ) 2 , CNOH, CNOCH 3 , OH, (O), CN, NO 2 , CF 3 , CF 2 CF 3 , OCF 3 , OCF 2 CF 3 , F, Cl, Br and I;

A 4 , at each occurrence, is a substituent on a substitutable position of the benzene ring of the indane independently selected from the group consisting of C 1 -C 6 alkyl, OH, F, Cl, Br and I;

A 5 is a substituent on a substitutable position of the cyclopentane ring of the indane independently selected from the group consisting of C 1 -C 6 alkyl, OH, F, Cl, Br and I;

R 1 , at each occurrence, is independently selected from the group consisting of C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, aryl, heteroaryl, heterocyclyl, cycloalkyl, and cycloalkenyl; wherein each R 1 C 1 -C 6 alkyl, C 2 -C 6 alkenyl, and C 2 -C 6 alkynyl is optionally substituted with one or more substituents independently selected from the group consisting of R 2 , OR 2 , SR 2 , S(O)R 2 , SO 2 R 2 , C(O)R 2 , CO(O)R 2 , OC(O)R 2 , OC(O)OR 2 , NH 2 , NHR 2 , N(R 2 ) 2 , NHC(O)R 2 , NR 2 C(O)R 2 , NHS(O) 2 R 2 , NR 2 S(O) 2 R 2 , NHC(O)OR 2 , NR 2 C(O)OR 2 , NHC(O)NH 2 , NHC(O)NHR 2 , NHC(O)N(R 2 ) 2 , NR 2 C(O)NHR 2 , NR 2 C(O)N(R 2 ) 2 , C(O)NH 2 , C(O)NHR 2 , C(O)N(R 2 ) 2 , C(O)NHOH, C(O)NHOR 2 , C(O)NHSO 2 R 2 , C(O)NR 2 SO 2 R 2 , SO 2 NH 2 , SO 2 NHR 2 , SO 2 N(R 2 ) 2 , C(O)H, C(O)OH, OH, (O), CN, NO 2 , CF 3 , CF 2 CF 3 , OCF 3 , OCF 2 CF 3 , F, Cl, Br and I; wherein each R 1 aryl, heteroaryl, heterocyclyl, cycloalkyl, and cycloalkenyl is optionally substituted with one or more substituents independently selected from the group consisting of R 3 , OR 3 , SR 3 , S(O)R 3 , SO 2 R 3 , C(O)R 3 , CO(O)R 3 , OC(O)R 3 , OC(O)OR 3 , NH 2 , NHR 3 , N(R 3 ) 2 , NHC(O)R 3 , NR 3 C(O)R 3 , NHS(O) 2 R 3 , NR 3 S(O) 2 R 3 , NHC(O)OR 3 , NR 3 C(O)OR 3 , NHC(O)NH 2 , NHC(O)NHR 3 , NHC(O)N(R 3 ) 2 , NR 3 C(O)NHR 3 , NR 3 C(O)N(R 3 ) 2 , C(O)NH 2 , C(O)NHR 3 , C(O)N(R 3 ) 2 , C(O)NHOH, C(O)NHOR 3 , C(O)NHSO 2 R 3 , C(O)NR 3 SO 2 R 3 , SO 2 NH 2 , SO 2 NHR 3 , SO 2 N(R 3 ) 2 , C(O)H, C(O)OH, C(O)C(O)NH 2 , C(O)C(O)NHR 3 , C(O)C(O)N(R 3 ) 2 , C(N)NH 2 , C(N)NHR 3 , C(N)N(R 3 ) 2 , CNOH, CNOCH 3 , OH, (O), CN, NO 2 , CF 3 , CF 2 CF 3 , OCF 3 , OCF 2 CF 3 , F, Cl, Br and I;

R 2 , at each occurrence, is independently selected from the group consisting of C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, aryl, heteroaryl, heterocyclyl, cycloalkyl, and cycloalkenyl; wherein each R 2 C 1 -C 6 alkyl, C 2 -C 6 alkenyl, and C 2 -C 6 alkynyl is optionally substituted with one or more substituents independently selected from the group consisting of NH 2 , C(O)NH 2 , SO 2 NH 2 , C(O)H, C(O)OH, OH, (O), CN, NO 2 , CF 3 , CF 2 CF 3 , OCF 3 , OCF 2 CF 3 , F, Cl, Br and I; wherein each R 2 aryl, heteroaryl, heterocyclyl, cycloalkyl, and cycloalkenyl is optionally substituted with one or more substituents independently selected from the group consisting of NH 2 , C(O)NH 2 , SO 2 NH 2 , C(O)H, C(O)OH, OH, (O), CN, NO 2 , CF 3 , CF 2 CF 3 , OCF 3 , OCF 2 CF 3 , F, Cl, Br and I;

R 3 , at each occurrence, is independently selected from the group consisting of C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, aryl, heteroaryl, heterocyclyl, cycloalkyl, and cycloalkenyl; wherein each R 3 C 1 -C 6 alkyl, C 2 -C 6 alkenyl, and C 2 -C 6 alkynyl is optionally substituted with one or more substituents independently selected from the group consisting of R 4 , OR 4 , SR 4 , S(O)R 4 , SO 2 R 4 , C(O)R 4 , CO(O)R 4 , OC(O)R 4 , OC(O)OR 4 , NH 2 , NHR 4 , N(R 4 ) 2 , NHC(O)R 4 , NR 4 C(O)R 4 , NHS(O) 2 R 4 , NR 4 S(O) 2 R 4 , NHC(O)OR 4 , NR 4 C(O)OR 4 , NHC(O)NH 2 , NHC(O)NHR 4 , NHC(O)N(R 4 ) 2 , NR 4 C(O)NHR 4 , NR 4 C(O)N(R 4 ) 2 , C(O)NH 2 , C(O)NHR 4 , C(O)N(R 4 ) 2 , C(O)NHOH, C(O)NHOR 4 , C(O)NHSO 2 R 4 , C(O)NR 4 SO 2 R 4 , SO 2 NH 2 , SO 2 NHR 4 , SO 2 N(R 4 ) 2 , C(O)H, C(O)OH, OH, (O), CN, NO 2 , CF 3 , CF 2 CF 3 , OCF 3 , OCF 2 CF 3 , F, Cl, Br and I; wherein each R 3 aryl, heteroaryl, heterocyclyl, cycloalkyl, and cycloalkenyl is optionally substituted with one or more substituents independently selected from the group consisting of R 5 , OR 5 , SR 5 , S(O)R 5 , SO 2 R 5 , C(O)R 5 , CO(O)R 5 , OC(O)R 5 , OC(O)OR 5 , NH 2 , NHR 5 , N(R 5 ) 2 , NHC(O)R 5 , NR 5 C(O)R 5 , NHS(O) 2 R 5 , NR 5 S(O) 2 R 5 , NHC(O)OR 5 , NR 5 C(O)OR 5 , NHC(O)NH 2 , NHC(O)NHR 5 , NHC(O)N(R 5 ) 2 , NR 5 C(O)NHR 5 , NR 5 C(O)N(R 5 ) 2 , C(O)NH 2 , C(O)NHR 5 , C(O)N(R 5 ) 2 , C(O)NHOH, C(O)NHOR 5 , C(O)NHSO 2 R 5 , C(O)NR 5 SO 2 R 5 , SO 2 NH 2 , SO 2 NHR 5 , SO 2 N(R 5 ) 2 , C(O)H, C(O)OH, C(N)NH 2 , C(N)NHR 5 , C(N)N(R 5 ) 2 , CNOH, CNOCH 3 , OH, (O), CN, NO 2 , CF 3 , CF 2 CF 3 , OCF 3 , OCF 2 CF 3 , F, Cl, Br and I;

R 4 is at each occurrence, is independently selected from the group consisting of C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, aryl, heteroaryl, heterocyclyl, cycloalkyl, and cycloalkenyl; wherein each R 4 C 1 -C 6 alkyl, C 2 -C 6 alkenyl, and C 2 -C 6 alkynyl is optionally substituted with one or more substituents independently selected from the group consisting of NH 2 , C(O)NH 2 , SO 2 NH 2 , C(O)H, C(O)OH, OH, (O), CN, NO 2 , CF 3 , CF 2 CF 3 , OCF 3 , OCF 2 CF 3 , F, Cl, Br and I; wherein each R 4 aryl, heteroaryl, heterocyclyl, cycloalkyl, and cycloalkenyl is optionally substituted with one or more substituents independently selected from the group consisting of NH 2 , C(O)NH 2 , SO 2 NH 2 , C(O)H, C(O)OH, OH, (O), CN, NO 2 , CF 3 , CF 2 CF 3 , OCF 3 , OCF 2 CF 3 , F, Cl, Br and I;

R 5 is at each occurrence, is independently selected from the group consisting of C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, aryl, heteroaryl, heterocyclyl, cycloalkyl, and cycloalkenyl; wherein each R 5 C 1 -C 6 alkyl, C 2 -C 6 alkenyl, and C 2 -C 6 alkynyl is optionally substituted with one or more substituents independently selected from the group consisting of NH 2 , C(O)NH 2 , SO 2 NH 2 , C(O)H, C(O)OH, OH, (O), CN, NO 2 , CF 3 , CF 2 CF 3 , OCF 3 , OCF 2 CF 3 , F, Cl, Br and I; wherein each R 5 aryl, heteroaryl, heterocyclyl, cycloalkyl, and cycloalkenyl is optionally substituted with one or more substituents independently selected from the group consisting of NH 2 , C(O)NH 2 , SO 2 NH 2 , C(O)H, C(O)OH, OH, (O), CN, NO 2 , CF 3 , CF 2 CF 3 , OCF 3 , OCF 2 CF 3 , F, Cl, Br and I;

n is 0, 1, or 2; and

m is 0 or 1.

2. A compound of Formula (IIIa) or Formula (IIIb), or a pharmaceutically acceptable salt thereof,

wherein

A 3 is selected from the group consisting of aryl, heterocyclyl, and heteroaryl, wherein the A 3 aryl, heterocyclyl, and heteroaryl are optionally substituted with one or more substituents independently selected from the group consisting of R 1 , OR 1 , SR 1 , S(O)R 1 , SO 2 R 1 , C(O)R 1 , CO(O)R 1 , OC(O)R 1 , OC(O)OR 1 , NH 2 , NHR 1 , N(R 1 ) 2 , NHC(O)R 1 , NR 1 C(O)R 1 , NHS(O) 2 R 1 , NR 1 S(O) 2 R 1 , NHC(O)OR 1 , NR 1 C(O)OR 1 , NHC(O)NH 2 , NHC(O)NHR 1 , NHC(O)N(R 1 ) 2 , NR 1 C(O)NHR 1 , NR 1 C(O)N(R 1 ) 2 , C(O)NH 2 , C(O)NHR 1 , C(O)N(R 1 ) 2 , C(O)NHOH, C(O)NHOR 1 , C(O)NHSO 2 R 1 , C(O)NR 1 SO 2 R 1 , SO 2 NH 2 , SO 2 NHR 1 , SO 2 N(R 1 ) 2 , C(O)H, C(O)OH, C(N)NH 2 , C(N)NHR 1 , C(N)N(R 1 ) 2 , CNOH, CNOCH 3 , OH, (O), CN, NO 2 , CF 3 , CF 2 CF 3 , OCF 3 , OCF 2 CF 3 , F, Cl, Br and I;

R 1 , at each occurrence, is independently selected from the group consisting of C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, aryl, heteroaryl, heterocyclyl, cycloalkyl, and cycloalkenyl; wherein each R 1 C 1 -C 6 alkyl, C 2 -C 6 alkenyl, and C 2 -C 6 alkynyl is optionally substituted with one or more substituents independently selected from the group consisting of R 2 , OR 2 , SR 2 , S(O)R 2 , SO 2 R 2 , C(O)R 2 , CO(O)R 2 , OC(O)R 2 , OC(O)OR 2 , NH 2 , NHR 2 , N(R 2 ) 2 , NHC(O)R 2 , NR 2 C(O)R 2 , NHS(O) 2 R 2 , NR 2 S(O) 2 R 2 , NHC(O)OR 2 , NR 2 C(O)OR 2 , NHC(O)NH 2 , NHC(O)NHR 2 , NHC(O)N(R 2 ) 2 , NR 2 C(O)NHR 2 , NR 2 C(O)N(R 2 ) 2 , C(O)NH 2 , C(O)NHR 2 , C(O)N(R 2 ) 2 , C(O)NHOH, C(O)NHOR 2 , C(O)NHSO 2 R 2 , C(O)NR 2 SO 2 R 2 , SO 2 NH 2 , SO 2 NHR 2 , SO 2 N(R 2 ) 2 , C(O)H, C(O)OH, OH, (O), CN, NO 2 , CF 3 , CF 2 CF 3 , OCF 3 , OCF 2 CF 3 , F, Cl, Br and I; wherein each R 1 aryl, heteroaryl, heterocyclyl, cycloalkyl, and cycloalkenyl is optionally substituted with one or more substituents independently selected from the group consisting of R 3 , OR 3 , SR 3 , S(O)R 3 , SO 2 R 3 , C(O)R 3 , CO(O)R 3 , OC(O)R 3 , OC(O)OR 3 , NH 2 , NHR 3 , N(R 3 ) 2 , NHC(O)R 3 , NR 3 C(O)R 3 , NHS(O) 2 R 3 , NR 3 S(O) 2 R 3 , NHC(O)OR 3 , NR 3 C(O)OR 3 , NHC(O)NH 2 , NHC(O)NHR 3 , NHC(O)N(R 3 ) 2 , NR 3 C(O)NHR 3 , NR 3 C(O)N(R 3 ) 2 , C(O)NH 2 , C(O)NHR 3 , C(O)N(R 3 ) 2 , C(O)NHOH, C(O)NHOR 3 , C(O)NHSO 2 R 3 , C(O)NR 3 SO 2 R 3 , SO 2 NH 2 , SO 2 NHR 3 , SO 2 N(R 3 ) 2 , C(O)H, C(O)OH, C(O)C(O)NH 2 , C(O)C(O)NHR 3 , C(O)C(O)N(R 3 ) 2 , C(N)NH 2 , C(N)NHR 3 , C(N)N(R 3 ) 2 , CNOH, CNOCH 3 , OH, (O), CN, NO 2 , CF 3 , CF 2 CF 3 , OCF 3 , OCF 2 CF 3 , F, Cl, Br and I;

R 2 , at each occurrence, is independently selected from the group consisting of C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, aryl, heteroaryl, heterocyclyl, cycloalkyl, and cycloalkenyl; wherein each R 2 C 1 -C 6 alkyl, C 2 -C 6 alkenyl, and C 2 -C 6 alkynyl is optionally substituted with one or more substituents independently selected from the group consisting of NH 2 , C(O)NH 2 , SO 2 NH 2 , C(O)H, C(O)OH, OH, (O), CN, NO 2 , CF 3 , CF 2 CF 3 , OCF 3 , OCF 2 CF 3 , F, Cl, Br and I; wherein each R 2 aryl, heteroaryl, heterocyclyl, cycloalkyl, and cycloalkenyl is optionally substituted with one or more substituents independently selected from the group consisting of NH 2 , C(O)NH 2 , SO 2 NH 2 , C(O)H, C(O)OH, OH, (O), CN, NO 2 , CF 3 , CF 2 CF 3 , OCF 3 , OCF 2 CF 3 , F, Cl, Br and I;

R 3 , at each occurrence, is independently selected from the group consisting of C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, aryl, heteroaryl, heterocyclyl, cycloalkyl, and cycloalkenyl; wherein each R 3 C 1 -C 6 alkyl, C 2 -C 6 alkenyl, and C 2 -C 6 alkynyl is optionally substituted with one or more substituents independently selected from the group consisting of R 4 , OR 4 , SR 4 , S(O)R 4 , SO 2 R 4 , C(O)R 4 , CO(O)R 4 , OC(O)R 4 , OC(O)OR 4 , NH 2 , NHR 4 , N(R 4 ) 2 , NHC(O)R 4 , NR 4 C(O)R 4 , NHS(O) 2 R 4 , NR 4 S(O) 2 R 4 , NHC(O)OR 4 , NR 4 C(O)OR 4 , NHC(O)NH 2 , NHC(O)NHR 4 , NHC(O)N(R 4 ) 2 , NR 4 C(O)NHR 4 , NR 4 C(O)N(R 4 ) 2 , C(O)NH 2 , C(O)NHR 4 , C(O)N(R 4 ) 2 , C(O)NHOH, C(O)NHOR 4 , C(O)NHSO 2 R 4 , C(O)NR 4 SO 2 R 4 , SO 2 NH 2 , SO 2 NHR 4 , SO 2 N(R 4 ) 2 , C(O)H, C(O)OH, OH, (O), CN, NO 2 , CF 3 , CF 2 CF 3 , OCF 3 , OCF 2 CF 3 , F, Cl, Br and I; wherein each R 3 aryl, heteroaryl, heterocyclyl, cycloalkyl, and cycloalkenyl is optionally substituted with one or more substituents independently selected from the group consisting of R 5 , OR 5 , SR 5 , S(O)R 5 , SO 2 R 5 , C(O)R 5 , CO(O)R 5 , OC(O)R 5 , OC(O)OR 5 , NH 2 , NHR 5 , N(R 5 ) 2 , NHC(O)R 5 , NR 5 C(O)R 5 , NHS(O) 2 R 5 , NR 5 S(O) 2 R 5 , NHC(O)OR 5 , NR 5 C(O)OR 5 , NHC(O)NH 2 , NHC(O)NHR 5 , NHC(O)N(R 5 ) 2 , NR 5 C(O)NHR 5 , NR 5 C(O)N(R 5 ) 2 , C(O)NH 2 , C(O)NHR 5 , C(O)N(R 5 ) 2 , C(O)NHOH, C(O)NHOR 5 , C(O)NHSO 2 R 5 , C(O)NR 5 SO 2 R 5 , SO 2 NH 2 , SO 2 NHR 5 , SO 2 N(R 5 ) 2 , C(O)H, C(O)OH, C(N)NH 2 , C(N)NHR 5 , C(N)N(R 5 ) 2 , CNOH, CNOCH 3 , OH, (O), CN, NO 2 , CF 3 , CF 2 CF 3 , OCF 3 , OCF 2 CF 3 , F, Cl, Br and I;

R 4 is at each occurrence, is independently selected from the group consisting of C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, aryl, heteroaryl, heterocyclyl, cycloalkyl, and cycloalkenyl; wherein each R 4 C 1 -C 6 alkyl, C 2 -C 6 alkenyl, and C 2 -C 6 alkynyl is optionally substituted with one or more substituents independently selected from the group consisting of NH 2 , C(O)NH 2 , SO 2 NH 2 , C(O)H, C(O)OH, OH, (O), CN, NO 2 , CF 3 , CF 2 CF 3 , OCF 3 , OCF 2 CF 3 , F, Cl, Br and I; wherein each R 4 aryl, heteroaryl, heterocyclyl, cycloalkyl, and cycloalkenyl is optionally substituted with one or more substituents independently selected from the group consisting of NH 2 , C(O)NH 2 , SO 2 NH 2 , C(O)H, C(O)OH, OH, (O), CN, NO 2 , CF 3 , CF 2 CF 3 , OCF 3 , OCF 2 CF 3 , F, Cl, Br and I; and

R 5 is at each occurrence, is independently selected from the group consisting of C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, aryl, heteroaryl, heterocyclyl, cycloalkyl, and cycloalkenyl; wherein each R 5 C 1 -C 6 alkyl, C 2 -C 6 alkenyl, and C 2 -C 6 alkynyl is optionally substituted with one or more substituents independently selected from the group consisting of NH 2 , C(O)NH 2 , SO 2 NH 2 , C(O)H, C(O)OH, OH, (O), CN, NO 2 , CF 3 , CF 2 CF 3 , OCF 3 , OCF 2 CF 3 , F, Cl, Br and I; wherein each R 5 aryl, heteroaryl, heterocyclyl, cycloalkyl, and cycloalkenyl is optionally substituted with one or more substituents independently selected from the group consisting of NH 2 , C(O)NH 2 , SO 2 NH 2 , C(O)H, C(O)OH, OH, (O), CN, NO 2 , CF 3 , CF 2 CF 3 , OCF 3 , OCF 2 CF 3 , F, Cl, Br and I.

3. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein A 1 and A 2 are each CH 3 .

4. The compound of claim 1 or a pharmaceutically acceptable salt thereof, wherein A 3 is aryl, wherein the A 3 aryl is optionally substituted with one or more substituents independently selected from the group consisting of R 1 , OR 1 , SO 2 R 1 , C(O)R 1 , CO(O)R 1 , C(O)NH 2 , C(O)NHR 1 , C(O)N(R 1 ) 2 , SO 2 NH 2 , C(O)OH, CN, F, Cl, Br and I.

5. The compound of claim 1 or a pharmaceutically acceptable salt thereof, wherein A 3 is heterocyclyl, wherein the A 3 heterocyclyl is optionally substituted with one or more substituents independently selected from the group consisting of R 1 , OR 1 , SO 2 R 1 , C(O)R 1 , CO(O)R 1 , C(O)NH 2 , C(O)NHR 1 , C(O)N(R 1 ) 2 , SO 2 NH 2 , C(O)OH, CN, F, Cl, Br and I.

6. The compound of claim 1 or a pharmaceutically acceptable salt thereof, wherein A 3 is heteroaryl, wherein the A 3 heteroaryl is optionally substituted with one or more substituents independently selected from the group consisting of R 1 , OR 1 , SO 2 R 1 , C(O)R 1 , CO(O)R 1 , C(O)NH 2 , C(O)NHR 1 , C(O)N(R 1 ) 2 , SO 2 NH 2 , C(O)OH, CN, F, Cl, Br and I.

7. A compound selected from the group consisting of

(3R,4S)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-4-{4-[4-(methanesulfonyl)piperazin-1-yl]phenyl}-N,N-dimethylpyrrolidin-3-amine;

rac-(3R,4S)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-4-{4-[4-(methanesulfonyl)piperazin-1-yl]phenyl}-N,N-dimethylpyrrolidin-3-amine;

(3S,4R)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-4-{4-[4-(methanesulfonyl)piperazin-1-yl]phenyl}-N,N-dimethylpyrrolidin-3-amine;

(3S,4R)-1-[(1S)-7-fluoro-2,3-dihydro-1H-inden-1-yl]-4-{4-[4-(methanesulfonyl)piperazin-1-yl]phenyl}-N,N-dimethylpyrrolidin-3-amine;

(3S,4R)-1-[(1R)-7-fluoro-2,3-dihydro-1H-inden-1-yl]-4-{4-[4-(methanesulfonyl)piperazin-1-yl]phenyl}-N,N-dimethylpyrrolidin-3-amine;

rac-(3S,4R)-4-(4-bromophenyl)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethylpyrrolidin-3-amine;

rac-(3S,4R)-4-(4-chlorophenyl)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethylpyrrolidin-3-amine;

rac-4-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]benzene-1-sulfonamide;

(3R,4S)-1-[(1S)-2,3-dihydro-1H-inden-1-yl]-4-[4-(methanesulfonyl)phenyl]-N,N-dimethylpyrrolidin-3-amine;

(3S,4R)-1-[(1S)-2,3-dihydro-1H-inden-1-yl]-4-[4-(methanesulfonyl)phenyl]-N,N-dimethylpyrrolidin-3-amine;

(3R,4S)-1-[(1S)-7-fluoro-2,3-dihydro-1H-inden-1-yl]-4-[4-(methanesulfonyl)phenyl]-N,N-dimethylpyrrolidin-3-amine;

(3R,4S)-1-[(1R)-7-fluoro-2,3-dihydro-1H-inden-1-yl]-4-[4-(methane sulfonyl)phenyl]-N,N-dimethylpyrrolidin-3-amine;

(3S,4R)-1-[(1S)-7-fluoro-2,3-dihydro-1H-inden-1-yl]-4-[4-(methanesulfonyl)phenyl]-N,N-dimethylpyrrolidin-3-amine;

(3S,4R)-1-[(1R)-7-fluoro-2,3-dihydro-1H-inden-1-yl]-4-[4-(methane sulfonyl)phenyl]-N,N-dimethylpyrrolidin-3-amine;

rac-(1S)-1-{(3S,4R)-3-(dimethylamino)-4-[4-(methanesulfonyl)phenyl]pyrrolidin-1-yl}-7-fluoro-2,3-dihydro-1H-inden-5-ol;

rac-(1R,3R)-3-{(3R,4S)-3-(dimethylamino)-4-[4-(methanesulfonyl)phenyl]pyrrolidin-1-yl}-4-fluoro-2,3-dihydro-1H-inden-1-ol;

rac-(1R)-1-{(3S,4R)-3-(dimethylamino)-4-[4-(methanesulfonyl)phenyl]pyrrolidin-1-yl}-7-fluoro-2,3-dihydro-1H-inden-5-ol;

rac-(1S,3S)-3-{(3R,4S)-3-(dimethylamino)-4-[4-(methanesulfonyl)phenyl]pyrrolidin-1-yl}-4-fluoro-2,3-dihydro-1H-inden-1-ol;

rac-4-{(3R,4S)-4-(dimethylamino)-1-[(1R)-7-fluoro-2,3-dihydro-1H-inden-1-yl]pyrrolidin-3-yl}benzonitrile;

rac-methyl 4-[(3R,4S)-1-[(1R)-2,3-dihydro-1H-inden-1-yl]-4-(dimethylamino)pyrrolidin-3-yl]benzoate;

rac-methyl 4-[(3S,4R)-1-(7-chloro-2,3-dihydro-1H-inden-1-yl)-4-(dimethylamino)pyrrolidin-3-yl]benzoate;

rac-methyl 4-[(3R,4S)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]benzoate;

rac-(3S,4R)-4-(3,4-dimethoxyphenyl)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethylpyrrolidin-3-amine;

rac-4-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-N-methylbenzamide;

rac-4-[(3S,4R)-1-(7-chloro-2,3-dihydro-1H-inden-1-yl)-4-(dimethylamino)pyrrolidin-3-yl]-N-dimethylbenzamide;

rac-4-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-N,N-dimethylbenzamide;

rac-(3R,4S)-4-(4-bromo-3-methylphenyl)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethylpyrrolidin-3-amine;

rac-4-[(3S,4R)-1-(7-chloro-2,3-dihydro-1H-inden-1-yl)-4-(dimethylamino)pyrrolidin-3-yl]benzoic acid;

rac-4-[(3R,4S)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]benzoic acid;

rac-(3R,4S)-1-[(3S)-3,7-difluoro-2,3-dihydro-1H-inden-1-yl]-4-[4-(methanesulfonyl)phenyl]-N,N-dimethylpyrrolidin-3-amine;

rac-(3R,4S)-1-[(1R,3S)-3,7-difluoro-2,3-dihydro-1H-inden-1-yl]-4-[4-(methanesulfonyl)phenyl]-N,N-dimethylpyrrolidin-3-amine;

rac-(3R,4S)-1-[(1S,3S)-3,7-difluoro-2,3-dihydro-1H-inden-1-yl]-4-[4-(methanesulfonyl)phenyl]-N,N-dimethylpyrrolidin-3-amine;

(3S)-3-{(3S,4R)-3-(dimethylamino)-4-[4-(methanesulfonyl)phenyl]pyrrolidin-1-yl}-4-fluoro-2,3-dihydro-1H-inden-1-ol;

rac-(1R,3S)-3-{(3R,4S)-3-(dimethylamino)-4-[4-(methanesulfonyl)phenyl]pyrrolidin-1-yl}-4-fluoro-2,3-dihydro-1H-inden-1-ol;

rac-4-[(3R,4S)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]benzamide;

rac-4-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-2-methylbenzoic acid;

rac-4-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-2-methylbenzonitrile;

rac-4-[(3S,4R)-4-(dimethylamino)-1-(2-hydroxy-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-2-methylbenzonitrile;

rac-methyl 4-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-2-methylbenzoate;

rac-{4-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]phenyl}[(3S)-3-hydroxypyrrolidin-1-yl]methanone;

rac-(3S,4R)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-[4-(piperazin-1-yl)phenyl]pyrrolidin-3-amine;

1-(4-{4-[(3S,4R)-1-(2,3-dihydro-1H-inden-1-yl)-4-(dimethylamino)pyrrolidin-3-yl]phenyl}piperazin-1-yl)ethan-1-one;

1-(4-{4-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]phenyl}piperazin-1-yl)ethan-1-one;

rac-1-(4-{4-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]phenyl}piperazin-1-yl)ethan-1-one;

1-[4-(4-{(3S,4R)-4-(dimethylamino)-1-[(1S)-7-fluoro-2,3-dihydro-1H-inden-1-yl]pyrrolidin-3-yl}phenyl)piperazin-1-yl]ethan-1-one;

1-[4-(4-{(3S,4R)-4-(dimethylamino)-1-[(1R)-7-fluoro-2,3-dihydro-1H-inden-1-yl]pyrrolidin-3-yl}phenyl)piperazin-1-yl]ethan-1-one;

1-[4-(4-{(3R,4S)-4-(dimethylamino)-1-[(1S)-7-fluoro-2,3-dihydro-1H-inden-1-yl]pyrrolidin-3-yl}phenyl)piperazin-1-yl]ethan-1-one;

1-[4-(4-{(3R,4S)-4-(dimethylamino)-1-[(1R)-7-fluoro-2,3-dihydro-1H-inden-1-yl]pyrrolidin-3-yl}phenyl)piperazin-1-yl]ethan-1-one;

rac-(3R,4S)-4-{4-[4-(ethanesulfonyl)piperazin-1-yl]phenyl}-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethylpyrrolidin-3-amine;

tert-butyl 4-{4-[(3R,4S)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]phenyl}piperazine-1-carboxylate;

rac-4-{4-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]benzoyl}-1-methylpiperazin-2-one;

rac-1-(4-{4-[(3R,4S)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]phenyl}piperazin-1-yl)-2-hydroxyethan-1-one;

rac-{4-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]phenyl}[4-(methanesulfonyl)piperazin-1-yl]methanone;

rac-2-(4-{4-[(3R,4S)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]phenyl}piperazin-1-yl)-2-oxoacetamide;

rac-1-(4-{4-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]benzoyl}piperazin-1-yl)ethan-1-one;

rac-4-{4-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]phenyl}-1-methylpiperazin-2-one;

rac-{4-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]phenyl}[4-(ethanesulfonyl)piperazin-1-yl]methanone;

rac-4-{4-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-2-methylphenyl}-1-methylpiperazin-2-one;

rac-2-(4-{4-[(3R,4S)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]phenyl}piperazin-1-yl)-N,N-dimethyl-2-oxoacetamide;

rac-1-(4-{4-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-2-methylphenyl}piperazin-1-yl)ethan-1-one;

rac-(3R,4S)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-[4-(4-methylpiperazin-1-yl)phenyl]pyrrolidin-3-amine;

rac-(3R,4S)-4-{4-[4-(ethanesulfonyl)piperazin-1-yl]-3-methylphenyl}-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethylpyrrolidin-3-amine;

rac-4-{4-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]phenyl}-N,N-dimethylpiperazine-1-carboxamide;

rac-(3R,4S)-4-[4-(4-cyclopropylpiperazin-1-yl)phenyl]-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethylpyrrolidin-3-amine;

rac-(3S,4R)-4-(2H-1,3-benzodioxol-5-yl)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethylpyrrolidin-3-amine;

rac-(3S,4R)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-[4-(1,3-oxazol-2-yl)phenyl]pyrrolidin-3-amine;

rac-(3R,4S)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-[4-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]pyrrolidin-3-amine;

rac-(3S,4R)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]pyrrolidin-3-amine;

rac-(3S,4R)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-[4-(4-methyl-1,3-oxazol-2-yl)phenyl]pyrrolidin-3-amine;

rac-(3R,4S)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-[4-(1-methyl-1H-pyrazol-4-yl)phenyl]pyrrolidin-3-amine;

rac-2-(4-{4-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]phenyl}-1H-pyrazol-1-yl)acetamide;

rac-2-(4-{4-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]phenyl}-1H-pyrazol-1-yl)-N-methylacetamide;

rac-(3S,4R)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-{4-[4-(1-methyl-1H-imidazole-4-sulfonyl)piperazin-1-yl]phenyl}pyrrolidin-3-amine;

rac-(3S,4R)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-{4-[4-(pyrimidin-4-yl)piperazin-1-yl]phenyl}pyrrolidin-3-amine;

rac-(3S,4R)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-{4-[4-(pyridin-2-yl)piperazin-1-yl]phenyl}pyrrolidin-3-amine;

(3R,4S)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-(1-methyl-1H-indol-3-yl)pyrrolidin-3-amine;

(3R,4S)-1-[(1S)-7-fluoro-2,3-dihydro-1H-inden-1-yl]-N,N-dimethyl-4-(1-methyl-1H-indol-3-yl)pyrrolidin-3-amine;

(3R,4S)-1-[(1R)-7-fluoro-2,3-dihydro-1H-inden-1-yl]-N,N-dimethyl-4-(1-methyl-1H-indol-3-yl)pyrrolidin-3-amine;

3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indole-7-carboxylic acid;

rac-3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indole-7-carboxylic acid;

3-[(3R,4S)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indole-7-carboxylic acid;

rac-methyl 3-[(3R,4S)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indole-6-carboxylate;

methyl 3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indole-7-carboxylate;

rac-methyl 3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indole-7-carboxylate;

methyl 3-[(3R,4S)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indole-7-carboxylate;

rac-3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-N,N,1-trimethyl-1H-indole-6-carboxamide;

(3R,4S)-1-(2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-(1-methyl-1H-indol-3-yl)pyrrolidin-3-amine;

(3R,4S)-1-(7-chloro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-(1-methyl-1H-indol-3-yl)pyrrolidin-3-amine;

rac-(3R,4S)-1-(4-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-(1-methyl-1H-indol-3-yl)pyrrolidin-3-amine;

rac-(3R,4S)-1-(5-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-(1-methyl-1H-indol-3-yl)pyrrolidin-3-amine;

rac-(3R,4S)-1-(6-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-(1-methyl-1H-indol-3-yl)pyrrolidin-3-amine;

rac-(3R,4S)-4-(7-bromo-1-methyl-1H-indol-3-yl)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethylpyrrolidin-3-amine;

rac-(3R,4S)-4-(6-bromo-1-methyl-1H-indol-3-yl)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethylpyrrolidin-3-amine;

rac-(3R,4S)-1-(5,7-difluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-(1-methyl-1H-indol-3-yl)pyrrolidin-3-amine;

(3R,4S)-1-(6,7-difluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-(1-methyl-1H-indol-3-yl)pyrrolidin-3-amine;

3-[(3R,4S)-3-(dimethylamino)-4-(1-methyl-1H-indol-3-yl)pyrrolidin-1-yl]-2,3-dihydro-1H-inden-4-ol;

rac-3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-N-(2-hydroxyethyl)-N,1-dimethyl-1H-indole-7-carboxamide;

rac-3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-N,1-dimethyl-1H-indole-7-carboxamide;

(3R,4S)—N,N-dimethyl-1-(7-methyl-2,3-dihydro-1H-inden-1-yl)-4-(1-methyl-1H-indol-3-yl)pyrrolidin-3-amine;

rac-3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-N,N,1-trimethyl-1H-indole-7-carboxamide;

{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indol-7-yl}(3-fluoroazetidin-1-yl)methanone;

rac-{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indol-7-yl}(3-fluoroazetidin-1-yl)methanone;

{3-[(3R,4S)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indol-7-yl}(3-fluoroazetidin-1-yl)methanone;

{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indol-7-yl}(3-hydroxyazetidin-1-yl)methanone;

rac-{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indol-7-yl}(3-hydroxyazetidin-1-yl)methanone;

rac-{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indol-6-yl}(3-hydroxyazetidin-1-yl)methanone;

rac-3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-N-(3-hydroxycyclobutyl)-1-methyl-1H-indole-7-carboxamide;

rac-3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-N-(3-hydroxycyclobutyl)-N,1-dimethyl-1H-indole-7-carboxamide;

rac-{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indol-7-yl}[3-(methanesulfonyl)azetidin-1-yl]methanone;

rac-{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indol-6-yl}[(3S)-3-hydroxypyrrolidin-1-yl]methanone;

rac-{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indol-6-yl}[(3R)-3-hydroxypyrrolidin-1-yl]methanone;

rac-[(3S,4S)-3,4-dihydroxypyrrolidin-1-yl]{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indol-7-yl}methanone;

rac-[(3S,4S)-3,4-dihydroxypyrrolidin-1-yl]{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indol-6-yl}methanone;

rac-3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-N-(1,1-dioxo-1lambda˜6˜-thiolan-3-yl)-1-methyl-1H-indole-7-carboxamide;

rac-{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indol-7-yl}[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]methanone;

rac-1-{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indole-7-carbonyl}-L-prolinamide;

rac-{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indol-7-yl}[(3S)-3-hydroxypyrrolidin-1-yl]methanone;

rac-{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indol-7-yl}(piperazin-1-yl)methanone;

rac-(3R,4S)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-4-{6-[4-(methanesulfonyl)piperazin-1-yl]-1-methyl-1H-indol-3-yl}-N,N-dimethylpyrrolidin-3-amine;

rac-1-(4-{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indol-6-yl}piperazin-1-yl)ethan-1-one;

rac-{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indol-6-yl}[4-(methanesulfonyl)piperazin-1-yl]methanone;

rac-1-(4-{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indole-6-carbonyl}piperazin-1-yl)ethan-1-one;

rac-4-{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indole-7-carbonyl}-N,N-dimethylpiperazine-1-sulfonamide;

rac-4-{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indole-7-carbonyl}-1-methylpiperazin-2-one;

rac-{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indol-7-yl}[4-(methanesulfonyl)piperazin-1-yl]methanone;

rac-4-{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indole-7-carbonyl}-N,N-dimethylpiperazine-1-carboxamide;

rac-1-(4-{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indole-7-carbonyl}piperazin-1-yl)ethan-1-one;

rac-4-{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indol-7-yl}-1-methylpiperazin-2-one;

rac-{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indol-7-yl}[4-(ethanesulfonyl)piperazin-1-yl]methanone;

rac-4-{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indol-7-yl}-N,N-dimethylpiperazine-1-carboxamide;

[4-(azetidine-1-sulfonyl)piperazin-1-yl]{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indol-7-yl}methanone;

1-(4-{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indole-7-carbonyl}piperazine-1-sulfonyl)azetidine-3-carbonitrile;

rac-8-{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indole-7-carbonyl}hexahydro-2H-pyrazino[1,2-a]pyrazin-1(6H)-one;

rac-{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indol-7-yl}[4-(1-methyl-1H-imidazole-5-sulfonyl)piperazin-1-yl]methanone;

rac-{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indol-7-yl}[4-(3,5-dimethyl-1H-pyrazole-4-sulfonyl)piperazin-1-yl]methanone;

rac-{3-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]-1-methyl-1H-indol-7-yl}[4-(pyridazin-3-yl)piperazin-1-yl]methanone;

rac-(3R,4S)-1-[(1S)-7-fluoro-2,3-dihydro-1H-inden-1-yl]-N,N-dimethyl-4-(1-methyl-1H-pyrrolo[3,2-b]pyridin-3-yl)pyrrolidin-3-amine;

rac-(3S,4R)-4-(2,3-dihydro-1-benzofuran-3-yl)-1-[(1R)-7-fluoro-2,3-dihydro-1H-inden-1-yl]-N,N-dimethylpyrrolidin-3-amine;

rac-(3S,4R)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-(5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-3-yl)pyrrolidin-3-amine;

rac-(3R,4S)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-(1-methyl-1H-pyrrolo[3,2-c]pyridin-3-yl)pyrrolidin-3-amine;

rac-(3R,4S)-4-(2,3-dihydro-1-benzofuran-3-yl)-1-[(1R)-7-fluoro-2,3-dihydro-1H-inden-1-yl]-N,N-dimethylpyrrolidin-3-amine;

rac-(3R,4S)-1-[(1R)-7-fluoro-2,3-dihydro-1H-inden-1-yl]-N,N-dimethyl-4-(1-methyl-1H-pyrrolo[3,2-b]pyridin-3-yl)pyrrolidin-3-amine;

rac-(3R,4S)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-(oxan-4-yl)pyrrolidin-3-amine;

rac-(3S,4R)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-[6-(piperazin-1-yl)pyridin-3-yl]pyrrolidin-3-amine;

rac-(3R,4S)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-(1-phenylpiperidin-4-yl)pyrrolidin-3-amine;

rac-2-(4-{5-[(3R,4S)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]pyridin-2-yl}piperazin-1-yl)-N,N-dimethylacetamide;

rac-(3R,4S)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-(1-methyl-1H-pyrrolo[2,3-c]pyridin-3-yl)pyrrolidin-3-amine;

rac-(3R,4S)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-[1-(pyridin-3-yl)piperidin-4-yl]pyrrolidin-3-amine;

rac-2-(4-{5-[(3R,4S)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]pyridin-2-yl}-1H-pyrazol-1-yl)-1-(3-hydroxyazetidin-1-yl)ethan-1-one;

rac-(4-{5-[(3R,4S)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]pyridin-2-yl}piperazin-1-yl)(oxetan-3-yl)methanone;

rac-(3R,4S)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-[1-(pyridin-2-yl)piperidin-4-yl]pyrrolidin-3-amine;

rac-2-(4-{5-[(3R,4S)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]pyridin-2-yl}-1H-pyrazol-1-yl)-1-(3-fluoroazetidin-1-yl)ethan-1-one;

rac-6-{4-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]piperidin-1-yl}-N-methylpyridine-3-carboxamide;

rac-N-[2-(4-{5-[(3R,4S)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]pyridin-2-yl}piperazin-1-yl)-2-oxoethyl]methanesulfonamide;

rac-(3R,4S)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-(1-methyl-1H-indazol-3-yl)pyrrolidin-3-amine;

rac-1-(4-{5-[(3R,4S)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]pyridin-2-yl}piperazin-1-yl)-2-(methanesulfonyl)ethan-1-one;

rac-2-(4-{5-[(3R,4S)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]pyridin-2-yl}-1H-pyrazol-1-yl)acetamide;

rac-2-(4-{5-[(3R,4S)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]pyridin-2-yl}-1H-pyrazol-1-yl)-N,N-dimethylacetamide;

rac-2-(4-{5-[(3R,4S)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]pyridin-2-yl}piperazin-1-yl)-2-oxoethane-1-sulfonamide;

rac-2-(4-{5-[(3R,4S)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]pyridin-2-yl}-1H-pyrazol-1-yl)-N-methylacetamide;

rac-2-{4-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]piperidin-1-yl}-1,3-thiazole-5-carboxamide;

rac-5-{4-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]piperidin-1-yl}pyrazine-2-carboxamide;

rac-(3R,4S)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrrolidin-3-amine;

rac-6-{4-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]piperidin-1-yl}pyridazine-3-carboxamide;

rac-4-{4-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]piperidin-1-yl}benzamide;

rac-6-{4-[(3S,4R)-4-(dimethylamino)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)pyrrolidin-3-yl]piperidin-1-yl}pyridine-3-carboxamide; and pharmaceutically acceptable salts thereof.

8. A pharmaceutical composition comprising a pharmaceutically acceptable excipient and a therapeutically effective amount of a compound of claim 1 or a pharmaceutically acceptable salt thereof.

9. A method of treating an EED-mediated cancer in a patient, comprising administering to a patient suffering from an EED-mediated cancer a therapeutically effective amount of a compound of claim 1 , or a pharmaceutically acceptable salt thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2018
From: CLARK, RICHARD F.; CURTIN, MICHAEL L.; FLORJANCIC, ALAN S.; JI, ZHIQIN; LI, HUAN-QIU; MICHAELIDES, MICHAEL R.; PLIUSHCHEV, MARINA A.; WANG, YING; ZHAO, HONGYU H.; MARIAZEL, TORRENT; SWEIS, RAMZI F.; VASUDEVAN, ANIL; DIETRICH, JUSTIN D.
To: ABBVIE INC.
Reel/Frame 045496/0886 →
Continuity (2)
Provisional Application 62332749 · May 6, 2016
Related Publication 20170320880A1 · Nov 9, 2017